Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Epizyme and GSK join to develop agents targeting histone methyltransferases

Jan. 18, 2011

Lilly and Boehringer Ingelheim enter global diabetes alliance

Jan. 18, 2011

Dyax and Sigma-Tau expand agreement to commercialize Kalbitor

Jan. 17, 2011

Celtic Therapeutics acquires RX-10045 from Resolvyx Pharma

Jan. 17, 2011

AstraZeneca and SCRI join to develop targeted anticancer agent

Jan. 13, 2011

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

Jan. 12, 2011

Bristol-Myers Squibb and Pharmasset to evaluate combination treatment for chronic hepatitis C

Jan. 12, 2011

Immutep and GSK enter into agreement for ImmuTune IMP-731

Jan. 12, 2011

Amgen grants MedImmune rights to develop AMG-108 worldwide outside Japan

Jan. 11, 2011

Ziopharm Oncology and Intrexon partner to develop DNA-based oncology therapeutics

Jan. 10, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...